Smith & Nephew Experiences Sustainable Growth

Smith & Nephew stock prices have been up nearly 25 percent this year, solidifying the orthopedic implant maker's economic recovery and leading the way to further hip and knee market growth, according to a report in The Wall Street Journal. Orthopedic growth slowed in Europe following an economic downturn, but it appears to finally be catching up to the U.K.-based S&N. In the third quarter, the company experienced hip and knee growth both at home and globally.

S&N is also looking to expand outside of hips and knees; its wound-care sales are forecasted to be about 30 percent of its total. Recent partnerships in Brazil and Turkey may also help propel the company in the next five years.

More Articles on Devices:
Boston Scientific's Spinal Cord Stimulator System Results in Significant Pain Reduction, Study Finds
Blue M Medical to Launch Operations in Indiana
Osseon Therapeutics Appoints Gary Hogman Regional Sales Director